Encouraging data are immerging in the field of RNAi of late.
The following link has yesterday been released by Alnylam.
http://www.smartbrief.com/news/aaaa/industryBW-detail.jsp?id=14AD7E1E-E359-4A6B-827B-91256141045D
The importance for Benitec is that Alnylam have a reciprocal agreement with them to use their technology in their trials. And gives further validation that the technology works.
here is a snippet:
"in vivo non-human primate data showing durable silencing of PCSK9 for more than 30 days following a single dose administration, with reduction in LDL cholesterol levels of approximately 50%;"
- Forums
- ASX - By Stock
- new pre-clinical research on rnai
Encouraging data are immerging in the field of RNAi of late.The...
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online